Views & Analysis Access to cancer drugs: planning for every outcome New UK oncology drug assessment procedures examined.
Views & Analysis A European perspective on oncology: ASCO review An overview of the latest on immunotherapies, progress in multiple myeloma and benefits of patient-reported outcomes.
US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
News EU regulators back blood cancer stem cell therapy Molmed's treatment aims to prevent reduce risk of graft-versus-host disease.
News FDA starts review of Regeneron's drug for rare disease FOP Can Regeneron's drug for ultra-rare bone disease FOP pick up the baton from Ipsen's Sohonos, whose growth has stalled?
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
